However, as CCL2 appears to be only a contributory factor to the carcinogenesis, we believe that in the absence of carcinogenic conditions such as end-stage ALD, its higher concentrations are not per se enough to facilitate HCC development. The gene discussed is CCL2; the disease is hepatocellular carcinoma.